RxDoctor Payments Data

Charles Jenkins, APRN

Family · Forest Park, GANPI 1841516630

Payments from drug & device makers

$484in general payments, 2019–2025

Across 15 payments — averaging $32.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$270
  • Redhill Biopharma Inc.$37
  • Amgen$36
  • Novo Nordisk$32
  • Pfizer$26
  • Hologic Sales And Service, LLC$23
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$484100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$484 in reported general payments places this provider in the 55th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$14,781
Medicare patients
36
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide21$21,684
JanuviaSitagliptin Phosphate13$15,909
TrulicityDulaglutide13$12,499
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$10,332
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,372
Advair HfaFluticasone Propion/Salmeterol15$6,596
Albuterol Sulfate HfaAlbuterol Sulfate162$5,663
Semglee (Yfgn) PenInsulin Glargine-Yfgn12$5,321
Amlodipine-ValsartanAmlodipine Besylate/Valsartan62$3,991
SymbicortBudesonide/Formoterol Fumarate15$3,464
BreynaBudesonide/Formoterol Fumarate14$2,118
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,743
Atorvastatin Calcium168$1,383
Gabapentin69$1,273
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide27$1,239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$32$21,68421 claims
GSKTrelegy Ellipta$17$8,37213 claims
AstraZenecaSymbicort$270$3,46415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,258 family providers in Georgia.

Other family in Forest Park

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →